Fingerprint
Dive into the research topics of 'Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Hagop M. Kantarjian, Jorge Cortes, Susan O'Brien, Francis J. Giles, Maher Albitar, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Deborah A. Thomas, Debra Resta, Moshe Talpaz
Research output: Contribution to journal › Article › peer-review